#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14402	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2203	649.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1472	1472	C	854	C	800	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26604	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3611	734.1	0	.	n	.	0	T695C	SNP	695	695	T	1108	1108	C	764	C,T	731,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26604	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3611	734.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1750	1750	A	902	A	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26604	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3611	734.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2384	2384	C	843	C	799	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26604	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3611	734.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3010	3010	T	804	T,C	768,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26604	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3611	734.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2458	2458	A	840	A	792	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	V36A	NONSYN	106	108	GTG	428	430	GCG	166;166;166	G;C;G	152;150;152	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	470	472	CGG	160;160;160	C;G;G,A	154;152;153,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	S68L	NONSYN	202	204	TCG	524	526	TTG	146;146;143	T;T;G	135;136;134	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	A90V	NONSYN	268	270	GCG	590	592	GTT	134;133;135	G;T;T	130;124;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	I105V	NONSYN	313	315	ATT	635	637	GTT	138;137;134	G;T;T	133;127;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	N125T	NONSYN	373	375	AAT	695	697	ACC	177;180;180	A;C;C	160;168;168	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	R135C	NONSYN	403	405	CGT	725	727	TGT	176;172;174	T;G;T	155;157;153	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	K151E	NONSYN	451	453	AAA	773	775	GAA	153;152;152	G;A;A	137;139;140	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	T152N	NONSYN	454	456	ACC	776	778	AAC	152;150;150	A;A;C,A	141;140;139,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	A172T	NONSYN	514	516	GCG	836	838	ACA	116;118;119	A;C;A	111;115;116	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	A175E	NONSYN	523	525	GCG	845	847	GAA	118;119;123	G;A;A	115;115;118	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	E176T	NONSYN	526	528	GAA	848	850	ACC	124;125;126	A;C;C	114;120;118	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	I178V	NONSYN	532	534	ATC	854	856	GTC	123;120;119	G;T;C	114;110;112	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	I188T	NONSYN	562	564	ATA	884	886	ACG	132;134;135	A;C;G	123;122;124	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	P200N	NONSYN	598	600	CCC	920	922	AAC	151;149;149	A;A;C	145;142;143	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	F220L	NONSYN	658	660	TTT	980	982	TTG	168;170;172	T;T;G	163;162;165	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1037	1039	ACC	141;140;139	A;C;C	133;133;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1040	1042	GAC	142;143;145	G;A;C	131;130;135	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1049	1051	GCG	153;149;146	G;C,A;G	142;123,1;134	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1085	1087	GCT	142;146;146	G;C;T	135;139;138	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1554	folP	858	858	91.61	folP.l6.c17.ctg.1	1647	93.9	1	SNP	p	R230S	1	.	.	688	690	AGC	1010	1012	AGC	168;166;166	A;G;C	159;158;156	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5162	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3596	143.0	1	SNP	p	S91F	0	.	.	271	273	TCC	645	647	TCC	175;173;172	T;C;C,G	162;164;160,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5162	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3596	143.0	1	SNP	p	D95N	0	.	.	283	285	GAC	657	659	GAC	181;180;180	G;A;C	166;164;163	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5162	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3596	143.0	1	SNP	p	D95G	0	.	.	283	285	GAC	657	659	GAC	181;180;180	G;A;C	166;164;163	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1684	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1349	123.8	1	SNP	p	G45D	1	.	.	133	135	GAC	434	436	GAC	219;219;218	G;A;C	203;206;207	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	922	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1107	83.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4896	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	170.4	1	SNP	p	D86N	0	.	.	256	258	GAC	537	539	GAC	181;181;181	G;A;C	171;171;172	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4896	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	170.4	1	SNP	p	S87I	0	.	.	259	261	AGT	540	542	AGT	184;185;186	A;G;T	175;175;176	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4896	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	170.4	1	SNP	p	S87W	0	.	.	259	261	AGT	540	542	AGT	184;185;186	A;G;T	175;175;176	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4896	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	170.4	1	SNP	p	S87R	0	.	.	259	261	AGT	540	542	AGT	184;185;186	A;G;T	175;175;176	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4896	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2855	170.4	1	SNP	p	S88P	0	.	.	262	264	TCC	543	545	TCC	187;185;189	T;C;C	178;176;180	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4132	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2569	159.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	178;176;178	G;G;C	165;165;165	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1282	1284	GCA	203;204;202	G;C;A	192;193;191	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1285	1287	ATC	201;203;207	A;T;C	192;192;194	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1297	1299	GTG	203;198;199	G;T;G	189;187;187	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1297	1299	GTG	203;198;199	G;T;G	189;187;187	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1801	1803	ACC	164;164;163	A;C;C	150;152;152	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1855	1857	GCG	174;173;176	G;C;G	156;140;148	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1855	1857	GCG	174;173;176	G;C;G	156;140;148	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1978	1980	GGC	133;133;132	G;G;C	129;127;126	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1987	1989	GGC	128;126;127	G;G;C	122;117;118	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	147.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2005	2007	CCG	113;117;119	C,G;C;G	86,2;88;91	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5494	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3204	170.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1705	1707	CTG	206;206;206	C;T;G	186;188;188	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2402	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1921	124.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	476	476	C	172	C	161	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	G38E	NONSYN	112	114	GGA	509	511	GAA	213;211;212	G;A;A	206;205;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	539	541	GGA	207;209;214	G;G;A	193;192;197	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	T87A	NONSYN	259	261	ACT	656	658	GCT	199;201;206	G;C;T	181;186;183	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	T89S	NONSYN	265	267	ACC	662	664	AGC	203;203;206	A;G;C,T	189;187;184,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	.	MULTIPLE	358	359	AA	754	755	CG	198;197	C;G	195;194	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	.	MULTIPLE	361	362	GA	757	759	CAG	198;193;194	C;A;G	194;191;191	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	N122K	NONSYN	364	366	AAC	761	763	AAA	195;192;190	A;A;A	192;190;187	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	K143E	NONSYN	427	429	AAA	824	826	GAA	212;212;212	G;A;A	201;200;200	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	848	850	GCA	211;215;212	G,A;C;A	195,1;199;196	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1031	1033	GAT	210;212;209	G;A;T	205;204;198	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1034	1036	GGT	208;207;204	G;G;T	201;202;197	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1049	1051	ATG	208;207;210	A;T;G	204;201;202	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1163	1165	GCA	209;208;212	G,A;C;A	202,1;202;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1166	1168	ACG	213;213;212	A,T;C,G;G	208,1;207,1;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1169	1171	GGG	212;209;208	G,C;G;G,C,T	203,1;202;202,1,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1172	1174	GTT	205;205;205	G;T,C;T	200;199,1;201	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1232	1234	GTA	218;217;219	G;T;A	203;202;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1271	1273	ACT	218;217;220	A;C;T	206;210;212	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1277	1279	GAT	222;221;223	G;A;T	213;211;214	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1289	1291	CAC	225;223;222	C;A;C	217;216;215	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	1	SNP	p	G120K	1	.	.	358	360	AAG	754	756	CGG	198;197;197	C;G;G	195;194;193	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	1	SNP	p	A121D	1	.	.	361	363	GAC	757	760	CGC	198;194;192	C;G;C	194;191;188	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2666	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1588	167.1	1	SNP	p	D121N	0	.	.	361	363	GAC	757	760	CGC	198;194;192	C;G;C	194;191;188	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10062	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4802	208.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1980	1982	CAT	208;209;209	C;A;T	198;201;202	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1138	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	950	118.4	1	SNP	p	V57M	1	.	.	169	171	ATG	485	487	ATG	221;223;224	A;T;G	211;213;212	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
